A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Conjupro Biotherapeutics, Inc.
Epsilogen Ltd
Conjupro Biotherapeutics, Inc.
GlaxoSmithKline
Rondo Therapeutics
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
Alterome Therapeutics, Inc.
Baptist Health South Florida
ViroMissile, Inc.
Replimune Inc.
Tizona Therapeutics, Inc
Angiex, Inc.
Novartis
OncoNano Medicine, Inc.
AbbVie
AstraZeneca
Hummingbird Bioscience
M.D. Anderson Cancer Center
Sanofi
Circle Pharma
Nurix Therapeutics, Inc.
Exelixis
AbbVie
Cancer Trials Ireland
Boehringer Ingelheim
AbbVie
City of Hope Medical Center
Williams Cancer Foundation
Tvardi Therapeutics, Incorporated
Zymeworks BC Inc.
Compugen Ltd
NantBioScience, Inc.
Carisma Therapeutics Inc
Jazz Pharmaceuticals
Eli Lilly and Company
Vincerx Pharma, Inc.
Vincerx Pharma, Inc.
Astellas Pharma Inc
Optimal Health Research
Pfizer
GlaxoSmithKline
Pfizer
Exelixis
University of Utah
Lebanese University
National Cancer Institute (NCI)
Pfizer
Multitude Therapeutics Inc.